Document is current
Any future updates will be listed below
-
Authors
Tullis, Jonathan E.
Larsen, Matthew E.
Rumian, Nicole L.
Freund, Ronald K. http://orcid.org/0000-0002-1850-1730
Boxer, Emma E. http://orcid.org/0000-0001-6190-5450
Brown, Carolyn Nicole
Coultrap, Steven J.
Schulman, Howard
Aoto, Jason
Dell’Acqua, Mark L.
Bayer, K. Ulrich http://orcid.org/0000-0003-0893-2200
- License Information
-
More Information
Article History
Received: 25 October 2022
Accepted: 20 July 2023
First Online: 30 August 2023
Competing interests
: The Regents of the University of Colorado have filed a provisional patent application, with inventors J.E.T., M.E.L., N.L.R. and K.U.B., capturing the findings reported in this manuscript. K.U.B. is a co-founder and board member of Neurexis Therapeutics, a company that seeks to develop a CaMKII inhibitor into a therapeutic drug for cerebral ischaemia. The other authors declare no competing interests.
